Agent Adds 2 Months to Gastric Ca Survival

Published January 16, 2014

Agent Adds 2 Months to Gastric Ca Survival
[rewrite]"This trial and the recently published REGARD trial demonstrate that ramucirumab is an effective new drug for the treatment of patients with metastatic or locally advanced unresectable gastric cancer and gastroesophageal junction cancer." The trial is …[/rewrite]
Read more on MedPage Today

FDA approves combo treatment for melanoma
[rewrite]The Food and Drug Administration has approved GlaxoSmithKline's Mekinist (trametinib) for use in combination with Tafinlar (dabrafenib) as a possible treatment for patients suffering from inoperable melanoma and certain types of metastatic melanoma …[/rewrite]
Read more on ModernMedicine

Drug Rehab in Baltimore — http://www.drugrehabbaltimoremd.com/ – If you your self or anyone you know is suffering from a drug addiction then we are here to help. Our state of the art …

Find More Drug Treatment Programs Maryland Information…